6533b829fe1ef96bd1289f9e
RESEARCH PRODUCT
Stress proteins HSP90 and Gp96 in graft-versus-host disease : pathophysiological, diagnostic and therapeutic implication
Antoine Seignezsubject
Maladie du greffon contre l’hôte intestinale17AAG[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyIntestinal graft-versus-host disease[SDV.IMM] Life Sciences [q-bio]/ImmunologyMaladie du greffon contre l’hôteHSP90Complement C3Complément C3Gp96Graft-versus-host diseasedescription
Allogeneic hematopoietic cell transplantation is a treatment for certain disorders including hematologic malignancies. Graft-versus-host-disease (GvHD) is a major, life-threatening complication. It is due to the recognition of recipient antigens by donor T cells, which activate and damage tissues. Intestinal barrier alteration plays a critical role in GvHD. Heat shock proteins (HSP)90 include five members, three cytosolic members named HSP90, and one member localized in endoplasmic reticulum (ER) called Gp96 and able to gain extracellular level in case of stress. We show in our thesis that 17AAG, a HSP90 inhibitor, reduces GvHD mortality in a mouse model. This effect is associated with an increase in ER stress pathway in intestinal epithelial cells as figured by transcription factor XBP-1 splicing, correlated to a decrease in intestinal tissue damage. These results suggest that 17AAG could be considered in GvHD prevention in human. Moreover, we show that Gp96 is secreted in serum of patients developing an acute GvHD with intestinal involvement. We propose to validate the relevance of Gp96 as an intestinal GvHD biomarker is a larger study. Finally, we find that Gp96 associate with complement component 3, a protein involved in innate and adaptive immunity, and inhibit some of its functions. Functional consequences of this association are discussed.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2015-01-01 |